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Purpose or Objective: To develop an infrastructure for 
structured and automated collection of interoperable 
radiation therapy (RT) data into a Swedish national quality 
register. 
 
Material and Methods: The present study was initiated in 
2012 with the participation of seven of the 15 Swedish clinics 
delivering radiation therapy. A national RT nomenclature and 
a database for structured unified storage of RT data at each 
clinic (Medical Information Quality Archive; MIQA) have been 
developed. Aggregated data from the MIQA databases are 
sent to a Swedish national RT register located on the same IT 
framework (INCA) as the national diagnosis-specific quality 
registries. 
 
Results: The suggested naming convention has to date been 
integrated into the clinical workflow at 12 sites and MIQA is 
installed at six of these. Involvement of the remaining 
Swedish RT clinics is ongoing, and they are expected to be 
part of the infrastructure by 2016. RT data collection from 
Aria®, Mosaiq®, Eclipse™, and Oncentra® is supported. 
Manual curation of RT-structure information is needed for 
approximately 10% of target volumes, but rarely for normal 
tissue structures, demonstrating a good compliance to the RT 
nomenclature. Aggregated dose/volume descriptors are 
calculated based on the information in MIQA and sent to INCA 
using a dedicated service (MIQA2INCA). Correct linkage of 
data for each patient to the diagnosis-specific quality 
registries on the INCA platform is assured by the unique 
Swedish personal identity number. 
 
Conclusion: An infrastructure for structured and automated 
prospective collection of syntactically interoperable radiation 
therapy data into a national register for RT data in Sweden 
has been implemented. Future developments include 
adapting MIQA to other treatment modalities (e.g. proton 
therapy and brachytherapy) and finding strategies to 
harmonize structure delineations. 
The database is built on the same platform as used by the 
diagnos specific quality registers in Sweden hosting 
information about additional treatments, clinical and patient 
reported outcomes. 
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Purpose or Objective: Modern radiotherapy routinely 
involves the use of small radiation fields, either for the 
delivery of stereotactic treatments, or as components of 
intensity-modulated radiation therapy (IMRT). The purpose of 
the small field dose rate dependence audit is to check 
dosimetric data in the treatment planning system (TPS), as 
used for patient Intensity Modulated Radiation Therapy 
(IMRT) treatments, related to a radiotherapy treatment unit 
equipped with an MLC. 
 
Material and Methods: The methodology worked out in the 
framework of the IAEA Coordinated Research Project 
E2.40.18 was used. The audit participants were asked to 
calculate the number of MUs for 5 MLC-shaped field sizes 
(10×10 cm2, 6×6 cm2, 4×4 cm2, 3×3 cm2 and 2×2 cm2) to 
deliver 10 Gy on axis at 10 cm depth, 100 cm SSD in water, 
using their treatment planning system. These calculations 
had to be repeated for each photon beam energy used for 
IMRT treatments. Eventually, they had to calculate the dose 
rate (Gy/MU) for each of the five MLC defined field sizes and 
normalize each value to the 10×10 cm2 value. These results 
were compared with the benchmark data from the 
publication: "The Radiological Physics Center’s standard 
dataset for small field size output factors" (Followill et al., 
Journal of Applied Clinical Medical Physics, 2012). Since this 
dataset did not provide data for certain beam qualities the 
interpolation/extrapolation was performed fitting the second 
degree polynomials to the RPC measured values. 
Results: The audit was performed in 32 (out of 35) Polish 
radiotherapy centres for different linacs, TPS, MLC types and 
beam energies. The beam qualities ranged from 4 MV to 20 
MV. In total, 81 beams were checked (Varian 41, Elekta 24, 
Siemens 16). When compared to the treatment planning 
system-calculated mean output factors, the RPC’s mean 
measured values agreed for all field sizes and energies within 
1% difference for Elekta machines. For Varian machines the 
difference exceeded 1% for 3×3 cm2 and 2×2 cm2 fields for 6 
MV beams (1.6% and 2.3%). For Siemens machines the 
differences exceeded 1% for 2×2 cm2 fields for both beam 
qualities 6 MV and 15 MV (1.6% and 1.7%). 
 
Conclusion: The RPC’s measured values provide a consistent 
dataset for small field output factors that can be used as a 
redundant QA check of a treatment planning system 
dosimetry data for small-field treatments. The RPC’s 
measured values have a small uncertainty (standard deviation 
< 2%), while the values calculated from the various planning 
systems and their beam models had a greater uncertainty, 
especially for the smallest field sizes. Such QA dataset 
against which the institution can compare its measured or 
calculated values is helpful to ensure accurate IMRT dose 
delivery by identifying discrepancies prior to any patients 
being treated. Any discrepancies noted between the standard 
dataset and calculated values should be investigated with 
careful measurements and with attention to the specific 
beam model. 
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Purpose or Objective: The medical linear accelerator(LINAC) 
is the most widely used in the modern radiation therapy. 
Recently, advanced radiation therapy technique require a 
high precision of the LINAC. Therefore, more precise quality 
assurance(QA) of the LINAC is required. In this study, we 
developed QA system using a video image for mechanical QA 
of LINAC. The our QA system may measure the mechanical 
isocenter offset(gantry, collimator, couch) and the couch 
movement. The purpose of this study was: ⓐthe 
Simplification of mechanical QA procedures, ⓑthe 
quantification of the measurement results, ⓒthe 
improvement of the measurement accuracy by eliminating 
the observers dependence. 
 
Material and Methods: The our QA system developed in this 
study use a method of analysis based on the recorded image 
by camera(Figure 1). Our QA system has configured the 
hardware into three parts. The first, it is a indicating unit 
pointing to the isocenter. The second, it is a recording unit 
for recording an image. Finally, the third, it is an analysis 
unit for analyzing the image. For the accuracy evaluation of 
the our QA system, we performed the two experiments. The 
first, it is the mechanical isocenter offset check for rotation 
of gantry and collimator. We measured the mechanical 
isocenter, and evaluated for the accuracy of the 
measurement about intentional offset distances(±1mm, 
±2mm). The second, it is couch movement check(direction of 
X, Y and Z). We compared the measured results by our QA 
system and the movement values shown in the R&V. 
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Figure 1. The configuration of the developed QA systems in 
this study. 
 
Results: In the mechanical isocenter offset check, the mean 
error is about 0.09 mm for gantry rotation, the maximum 
error is about 0.28 mm was measured. And the mean error is 
about 0.11 mm for collimator rotation, the maximum error is 
about 0.31 mm was measured. In the couch movement check, 
the mean error in the X-direction is about 0.17 mm, the 
mean error in the Y-direction is about 0.19 mm, and the 
mean error in the Z-direction is about 0.24 mm. 
 
Conclusion: In this study, we developed the QA system to 
improve the inefficient of the mechanical QA using 
conventional methods. At present, our QA system may 
measure the mechanical isocenter offset check and the couch 
movement check. The accuracy of measurement result is 
sufficient to measure the tolerances recommended in the 
guidelines. 
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Purpose or Objective: Purpose/Objective: To describe the 
extent of IROC Houston’s, formerly the Radiological Physics 
Center, QA activities and audit results for radiotherapy 
institutions outside of North America (NA). 
 
Material and Methods: Material/Method: The IROC Houston’s 
QA program components were designed to audit the radiation 
dose calculation chain from the NIST traceable reference 
beam calibration, to inclusion of dosimetry parameters used 
to calculate tumor doses, to the delivery of the radiation 
dose. The QA program provided to international institutions 
includes: 1) remote TLD/OSLD audit of machine output, 2) 
credentialing for advanced technologies, and 3) review of 
patient treatment records. IROC Houston uses the same 
standards and acceptance criteria for all of its audits 
whether for North American or international sites. 
 
Results: Results: IROC Houston’s QA program has reached out 
to radiotherapy sites in 43 different countries since 2013 
through their participation in clinical trials. In the past two 
years, 2,778 international megavoltage beam outputs were 
audited with OSLD/TLD. While the average IROC/Inst ratio is 
near unity for all sites monitored, there are international 
regions whose results are significantly different from the NA 
region as seen in Table 1. In the past 2 years, 477 and 87 
IMRT H&N phantoms were irradiated at NA and international 
sites, respectively. Regardless of the OSLD beam audit 
results, the overall pass rate (87 percent) for all international 
sites (no region separation) is equal to the NA sites. Of the 
182 international patient charts reviewed, 10.7 percent of 
the dose calculation points did not meet our acceptance 
criterion as compared to 13.6 percent for NA sites. The lower 
pass rate for NA sites results from a much larger 
brachytherapy component which has been shown to be more 
error prone. 
 
 
 
Conclusion: Conclusion: The IROC Houston QA Center has 
expanded its QA services worldwide and continues a long 
history of improving radiotherapy dose delivery in many 
countries. 
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Purpose or Objective: Metallic nanoparticles have shown 
radiosensitizing properties in cancer radiotherapy, with both 
conventional and hadron beams. In particular, Gold Nano 
Particles (GNPs) are emerging as promising enhancers for 
radiotherapy. However, the exact mechanisms behind the 
extra damage are yet unknown, although Reactive Oxygen 
Species (ROS) production, known to be crucial in 
radiotherapy, is a strong candidate. A direct measurements 
of ROS production was performed in typical radiotherapy 
treatment conditions. 
 
Material and Methods: A protocol for measuring the OH* 
radical production in Phosphate-buffered saline (PBS) 
solution, based on the fluorimetric properties of oxygen-
quenched Terephthalic acid, was designed and validated. 
Correction factors associated to GNP-induced adsorption, 
absorption and diffusion at the fluorimetric excitation and 
emission wavelengths were carefully evaluated. ROS 
production induced by 6 and 15 MV photon beams was then 
measured in standard PBS solution, as well as in the presence 
of GNPs of 5 nm and 20 nm diameters, at 5 μmol and 10 μmol 
concentrations. 
 
Results: A relevant ROS extra production was observed for 5 
nm diameter GNPs, up to about 40% at 10 μmol and 20% at 5 
μmol as a function of the delivered dose. Measurements with 
20 nm diameter GNPs are consistent with a ROS production 
increase of the order of 10%, albeit with a large experimental 
error. The ROS enhancement is consistent with the 
hypothesis of a linear dependence on the GNP surface to 
volume ratio, within the experimental errors. 
 
Conclusion: Further measurements with 10 nm and 2 nm 
GNPs are planned, in order to verify the linear dependence 
on the inverse GNP radius with higher precision over a wider 
size range. 
 
 
 
 
